查看購物車
  • Simplified Chinese
  • English
  • Japanese
美國孤兒食品市場規模、份額和趨勢分析報告：按給藥途徑、產品、應用、銷售渠道和細分市場預測，2023-2030 年
市場調查報告書
商品編碼
1233250

美國孤兒食品市場規模、份額和趨勢分析報告：按給藥途徑、產品、應用、銷售渠道和細分市場預測，2023-2030 年

U.S. Medical Foods For Orphan Disease Market Size, Share & Trends Analysis Report By Route Of Administration, By Product, By Application, By Sales Channel, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

美國罕見病食品市場的增長和趨勢

根據Grand View Research, Inc.的最新報告，2023年至2030年美國孤兒醫療食品市場將以5.6%的複合年增長率增長，2030年將達到5億份。預計達到 2750 萬美元。

不斷增長的醫療保健支出、對罕見疾病的認識、罕見疾病的流行、早期篩查等是推動市場增長的主要因素。 據美國食品和藥物管理局稱，苯丙酮尿症影響美國大約 15,000 人中的 1 人。 同樣，根據猶他州新生兒篩查數據，美國約有 250,000 名嬰兒中有 1 名患有 II 型酪氨酸血症。

在許多罕見疾病中，獨特的醫療飲食對於預防嚴重殘疾和促進兒童和成人的健康成長至關重要。 例如，楓糖漿尿症、食物蛋白引起的腸炎綜合症和短腸綜合症是一些常見的孤兒病，需要特殊飲食。 不含小麥、大豆、乳製品和其他過敏原的低過敏性牛奶經常被提供給患有 FPIES 的新生兒和兒童。 這些因素對於擴大規模仍然很重要。

COVID-19 大流行增加了重症患者的醫療保健服務負擔和治療敏感性。 COVID-19 檢測呈陽性的患者通常免疫系統較弱，呼吸系統和其他系統受損。 例如，根據發表在 Elsevier Public Health Emergency Collection 上的一篇論文，大約一半的 COVID-19 重症患者會出現胃腸道動力不足等胃腸道問題。 此外，患者出現各種腹部問題，導致採用醫療食品。

美國罕見病食品市場整合，達能、雅培、雀巢、美贊臣和 Relief Therapeutics 佔據多數份額。 這些玩家採用多種策略來增加他們的份額。 新產品開發、高研發投入以開發針對特定疾病的製劑等是參與者實施的一些策略。

美國孤兒食品市場報告要點。

  • 2022 年，按給藥途徑，口服部分的收入份額最高，收入份額為 70.8%。 然而，在預測期內，腸道途徑預計將以最快的速度增長。
  • 到 2022 年，粉末部分將佔收入份額的 35.3%，液體部分預計在預測期內也將以有利的速度增長。
  • 到 2022 年，其他業務部門佔據了大部分收入份額。 然而，FPIES 部分也有望在預測期內以有利的速度增長。
  • 到 2022 年，按銷售渠道劃分，設施銷售將佔市場的大部分，達到 41.1%。 然而，在線銷售部門預計在預測期內將有良好增長。

內容

第一章調查方法及範圍

  • 市場細分和範圍
  • 市場定義
  • 調查方法
    • 信息採購
      • 購買的數據庫：
      • GVR 內部數據庫
    • 初步調查：
  • 調查範圍和假設
  • 報價流程
  • 列表到數據源

第 2 章執行摘要

  • 市場展望
  • 細分市場展望
  • 競爭考慮
  • 美國罕見病食品市場概況

第 3 章。美國孤兒食品市場的變量、趨勢和範圍

  • 描繪滲透率和增長前景
  • 價格分析
  • 用戶視角分析
    • 消費者行為分析
    • 市場影響者分析
  • 技術展望
    • 技術時間表
  • 市場系列展望
    • 母公司市場展望
      • 保健品市場
    • 輔助市場展望
      • 父母營養品市場
      • 腸內餵養設備市場
  • 監管框架
    • 報銷框架
      • 美國
    • 標準、合規性和安全性
  • 市場動態
    • 市場驅動因素分析
      • 個性化治療的上升趨勢
      • 需要對患者進行營養管理的罕見病患病率上升
    • 市場製約因素分析
      • 醫學界缺乏認識
      • 醫療食品的高成本
    • 行業問題
      • 與小直徑連接器相關的並發症
      • 與腸內營養相關的風險
  • 美國孤兒醫療食品市場分析工具
    • 美國孤兒食品市場 - 波特分析
      • 供應商議價能力：中等
      • 買方議價能力：中等
      • 新進入者的威脅：低
      • 替代威脅：低
      • 競爭對手之間的敵意：高
    • PESTEL 分析
      • 政治和法律狀況
      • 經濟和社會狀況
      • 技術情況
  • COVID-19 對美國孤兒食品市場的影響

第 4 章美國孤兒食品市場：給藥途徑的估計和趨勢分析

  • 美國罕見病食品市場：應用變化分析，百萬美元，2022 年和 2030 年
  • 口語
  • 腸內

第 5 章美國孤兒食品市場：產品估計和趨勢分析

  • 美國孤兒食品市場：產品變化分析，2022 年和 2030 年，百萬美元
  • 藥片
  • 粉末
  • 液體
  • 其他

第 6 章美國孤兒食品市場：應用估計和趨勢分析

  • 美國罕見病食品市場：應用變化分析，2022 年和 2030 年，百萬美元
  • 苯丙酮尿症
  • 嗜酸性粒細胞性食管炎
  • 複製
  • 酪氨酸血症
  • 穆蘇德
  • 同型半胱氨酸尿症
  • 其他罕見病

第 7 章美國孤兒食品市場：銷售渠道估計和趨勢分析

  • 美國孤兒食品市場：2022 年和 2030 年銷售渠道變化分析，百萬美元
  • 在線銷售
  • 零售銷售
  • 機構銷售

第8章競爭分析

  • 主要市場進入者的近期趨勢和影響分析
  • 公司/競爭對手分類（主要創新者、市場領導者、初創企業）
  • 公司市場分析

第九章公司簡介

  • 達能
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • 雀巢
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • 雅培
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • 美贊臣公司
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • 救濟療法
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
Product Code: GVR-4-68040-038-6

U.S. Medical Foods For Orphan Disease Market Growth & Trends:

The U.S. medical foods for orphan disease market is expected to reach USD 527.5 million by 2030, expanding at a CAGR of 5.6% from 2023 to 2030, based on a new report by Grand View Research, Inc. Increasing healthcare expenditure, awareness about rare diseases, the prevalence of rare diseases, and early screening, are some of the key factors driving the growth of the market. As per the U.S. FDA, phenylketonuria affects about 1 in 15,000 people in the U.S. Similarly, as per the data published by UTAH's Newborn Screening, tyrosinemia type II affects approximately 1 in 250,000 babies in the U.S.

A unique medical diet is essential for a number of rare disorders in order to prevent severe impairments and promote healthy growth in children and adults. For instance, maple syrup urine disease, food protein-induced enterocolitis syndrome, and short bowel syndrome are some of the common orphan diseases that have specific dietary requirements. Hypoallergenic formulas free of wheat, soy, dairy, and other possible allergens are frequently provided to new-borns and kids with FPIES. These factors continue to be crucial for the expansion.

The COVID-19 pandemic increased the burden on healthcare services and of treatment sensitivity for critically ill patients. Patients who tested positive for COVID-19 typically suffered from weakened immunity and disruption in respiratory & other systems. For instance, according to an article published in Elsevier Public Health Emergency Collection, around half of the critically ill COVID-19 patients developed gastrointestinal problems, such as gastrointestinal hypomotility. Patients experienced various other abdominal issues, which led to increased adoption of medical foods.

The U.S. medical foods for orphan disease market is consolidated, wherein Danone, Abbott, Nestle, Mead Johnsons, and Relief Therapeutics account for the majority share. These players are adopting several strategies to increase their shares. The development of new products and high R&D investments to develop disease-specific formulas are some of the strategies players implement.

U.S. Medical Foods For Orphan Disease Market Report Highlight:

  • The oral route segment accounted for the highest revenue share in terms of route of administration in 2022 and its revenue share was 70.8%. However, the enteral route is anticipated to grow at the fastest rate over the forecast period.
  • The powder segment accounted for 35.3% of the revenue share in 2022, the liquid segment is also expected to grow at a lucrative rate over the forecast period.
  • The others segment accounted for the majority revenue share in 2022. However, FPIES segment is also expected to grow at a lucrative rate over the forecast period.
  • Institutional sales held the majority share of 41.1% the market in terms of sales channel in 2022. However, the online sales segment is expected to grow lucratively over the forecast period.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Market Definition
  • 1.3 Research Methodology
    • 1.3.1 Information Procurement
      • 1.3.1.1 Purchased Database:
      • 1.3.1.2 Gvr's Internal Database
    • 1.3.2 Primary Research:
  • 1.4 Research Scope and Assumptions
  • 1.5 Estimation Process
  • 1.6 List to Data Sources

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights
  • 2.4 U.S. Medical Foods for Orphan Disease Market Snapshot

Chapter 3 U.S. Medical Foods for Orphan Disease Market Variables, Trends & Scope

  • 3.1 Penetration and Growth Prospect Mapping
  • 3.2 Pricing Analysis
  • 3.3 User Perspective Analysis
    • 3.3.1 Consumer Behavior Analysis
    • 3.3.2 Market Influencer Analysis
  • 3.4 Technology Outlook
    • 3.4.1 Technology Timeline
  • 3.5 Market Lineage Outlook
    • 3.5.1 Parent Market Outlook
      • 3.5.1.1 Nutritional Supplements Market
    • 3.5.2 Ancillary Market Outlook
      • 3.5.2.1 Parenteral Nutrition Market
      • 3.5.2.2 Enteral Feeding Devices Market
  • 3.6 Regulatory Framework
    • 3.6.1 Reimbursement Framework
      • 3.6.1.1 U.S.
    • 3.6.2 Standards, Compliance, & Safety
  • 3.7 Market Dynamics
    • 3.7.1 Market Driver Analysis
      • 3.7.1.1 Rising Trend Of Personalized Treatment
      • 3.7.1.2 Rising Prevalence Of Orphan Diseases Requiring Nutritional Management Of Patients
    • 3.7.2 Market Restraint Analysis
      • 3.7.2.1 Lack Of Awareness Amongst The Medical Community
      • 3.7.2.1 High Cost Of Medical Foods
    • 3.7.3 Industry Challenge
      • 3.7.3.1 Complications Associated With Small-Bore Connectors
      • 3.7.3.1 Risks Associated With Enteral Feeding
  • 3.8 U.S. Medical Foods For Orphan Disease Market Analysis Tools
    • 3.8.1 U.S. Medical Foods For Orphan Disease Market - Porter's Analysis
      • 3.8.1.1 Bargaining Power Of Supplier: Moderate
      • 3.8.1.2 Bargaining Power Of Buyer: Moderate
      • 3.8.1.3 Threat Of New Entrants: Low
      • 3.8.1.4 Threat Of Substitution: Low
      • 3.8.1.5 Competitive Rivalry: High
    • 3.8.2 Pestel Analysis
      • 3.8.2.1 Political And Legal Landscape
      • 3.8.2.2 Economic And Social Landscape
      • 3.8.2.3 Technological Landscape
  • 3.9 Impact Of Covid-19 On The U.S. Medical Foods For Orphan Disease Market

Chapter 4 U.S. Medical Foods For Orphan Disease Market: Route Of Administration Estimates & Trend Analysis

  • 4.1 U.S. Medical Foods For Orphan Disease Market: Application Movement Analysis, USD Million, 2022 & 2030
  • 4.2 Oral
    • 4.2.1 Oral Market Estimates And Forecasts For Diabetic Neuropathy, 2018 - 2030 (USD Million)
  • 4.3 Enteral
    • 4.3.1 Enteral Market Estimates And Forecasts For Depression, 2018 - 2030 (USD Million)

Chapter 5 U.S. Medical Foods For Orphan Disease Market: Product Estimates & Trend Analysis

  • 5.1 U.S. Medical Foods For Orphan Disease Market: Product Movement Analysis, 2022 & 2030 USD Million
  • 5.2 Pills
    • 5.2.1 U.S. Medical Foods For Orphan Disease Market Forecasts For Pills Formulation, 2018 - 2030 (USD Million)
  • 5.3 Powder
    • 5.3.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Powder Formulation, 2018 - 2030 (USD Million)
  • 5.4 Liquid
    • 5.4.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Liquid Formulation, 2018 - 2030 (USD Million)
  • 5.5 Others
    • 5.5.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Other Formulations, 2018 - 2030 (USD Million)

Chapter 6 U.S. Medical Foods For Orphan Disease Market: Application Estimates & Trend Analysis

  • 6.1 U.S. Medical Foods For Orphan Disease Market: Application Movement Analysis, 2022 & 2030 USD Million
  • 6.2 Phenylketonuria
    • 6.2.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Phenylketonuria, 2018 - 2030 (USD Million)
  • 6.3 Eosinophilic Esophagitis
    • 6.3.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Eosinophilic Esophagitis, 2018 - 2030 (USD Million)
  • 6.4 Fpies
    • 6.4.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Fpies, 2018 - 2030 (USD Million)
  • 6.5 Tyrosinemia
    • 6.5.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Tyrosinemia, 2018 - 2030 (USD Million)
  • 6.6 Msud
    • 6.6.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Msud, 2018 - 2030 (USD Million)
  • 6.7 Homocystinuria
    • 6.7.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Homocystinuria, 2018 - 2030 (USD Million)
  • 6.8 Other Orphan Diseases
    • 6.8.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Other Orphan Disease, 2018 - 2030 (USD Million)

Chapter 7 U.S. Medical Foods For Orphan Disease Market: Sales Channel Estimates & Trend Analysis

  • 7.1 U.S. Medical Foods For Orphan Disease Market: Sales Channel Movement Analysis, 2022 & 2030 USD Million
  • 7.2 Online Sales
    • 7.2.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Online Sales Channel, 2018 - 2030 (USD Million)
  • 7.3 Retail Sales
    • 7.3.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Retail Sales Channel, 2018 - 2030 (USD Million)
  • 7.4 Institutional Sales
    • 7.4.1 U.S. Medical Foods For Orphan Disease Market Estimates And Forecasts For Institutional Sales Channel, 2018 - 2030 (USD Million)

Chapter 8 Competitive Analysis

  • 8.1 Recent Developments and Impact Analysis by Key Market Participants
  • 8.2 Company/Competition Categorization (Key Innovators, Market Leaders, and Emerging Players)
  • 8.3 Company Market Position Analysis

Chapter 9 Company Profiles

  • 9.1 DANONE
    • 9.1.1 Company overview
    • 9.1.2 Financial performance
    • 9.1.3 Product benchmarking
    • 9.1.4 Strategic initiatives
  • 9.2 NESTLE
    • 9.2.1 Company overview
    • 9.2.2 Financial performance
    • 9.2.3 Product benchmarking
    • 9.2.4 Strategic initiatives
  • 9.3 ABBOTT
    • 9.3.1 Company overview
    • 9.3.2 Financial performance
    • 9.3.3 Product benchmarking
    • 9.3.4 Strategic initiatives
  • 9.4 MEAD JOHNSON & COMPANY, LLC
    • 9.4.1 Company overview
    • 9.4.2 Financial performance
    • 9.4.3 Product benchmarking
    • 9.4.4 Strategic initiatives
  • 9.5 Relief Therapeutics
    • 9.5.1 Company overview
    • 9.5.2 Financial performance
    • 9.5.3 Product benchmarking
    • 9.5.4 Strategic initiatives

List of Tables

  • Table 1 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2018 - 2030 (USD Million)
  • Table 2 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 4 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 U.S. Medical Foods for Orphan Disease market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 U.S. Medical Foods for Orphan Disease market summary, 2022 (USD Million)
  • Fig. 6 U.S. Medical Foods for Orphan Disease market summary, 2022 (USD Million)
  • Fig. 7 U.S. Medical Foods for Orphan Disease market summary, 2022 (USD Million)
  • Fig. 8 U.S. Medical Foods for Orphan Disease market summary, 2022 (USD Million)
  • Fig. 9 Penetration & growth prospect mapping
  • Fig. 10 Consumer decision-making process
  • Fig. 11 Evolution of medical foods
  • Fig. 12 Parent market analysis, 2021
  • Fig. 13 Timeline for new ENFit Connectors
  • Fig. 14 Market driver analysis (Current & future impact)
  • Fig. 15 Market restraint analysis (Current & future impact)
  • Fig. 16 U.S. Medical Foods for Orphan Disease market, route of administration outlook key takeaways (USD Million)
  • Fig. 17 U.S. Medical Foods for Orphan Disease market: route of administration movement analysis (USD Million) 2022 & 2030
  • Fig. 18 Oral Disease market estimates and forecasts for diabetic neuropathy, 2018 - 2030 (USD Million)
  • Fig. 19 Enteral market estimates and forecasts for depression, 2018 - 2030 (USD Million)
  • Fig. 20 U.S. Medical foods for orphan disease market, product outlook: Key takeaways, USD Million
  • Fig. 21 U.S. Medical foods for orphan disease market: Product movement analysis, 2022 & 2030, (USD Million)
  • Fig. 22 U.S. Medical foods for orphan disease market estimates and forecasts for pills formulation, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Medical foods for orphan disease market estimates and forecasts for powder formulation, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. Medical foods for orphan disease market estimates and forecasts for liquid formulation, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. Medical foods for orphan disease market estimates and forecasts for other formulations, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. Medical foods for orphan disease market, application outlook: Key takeaways, USD Million
  • Fig. 27 U.S. Medical foods for orphan disease market: application movement analysis, 2022 & 2030, (USD Million)
  • Fig. 28 U.S. Medical foods for orphan disease market estimates and forecasts for phenylketonuria, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Medical foods for orphan disease market estimates and forecasts for Eosinophilic Esophagitis, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. Medical foods for orphan disease market estimates and forecasts for FPIES, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Medical foods for orphan disease market estimates and forecasts for tyrosinemia, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Medical foods for orphan disease market estimates and forecasts for MSUD, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Medical foods for orphan disease market estimates and forecasts for Homocystinuria, 2018 - 2030 (USD Million)
  • Fig. 34 U.S Medical foods for orphan disease market estimates and forecasts for other orphan disease, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Medical Foods for Orphan Disease market, sales channel outlook: Key takeaways, USD Million
  • Fig. 36 U.S. Medical Foods for Orphan Disease market: Sales channel movement analysis, 2022 & 2030, (USD Million)
  • Fig. 37 U.S. Medical foods for orphan disease market estimates and forecasts for online sales channel, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Medical foods for orphan disease market estimates and forecasts for retail sales channel, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. Medical foods for orphan disease market estimates and forecasts for institutional sales channel, 2018 - 2030 (USD Million)